WallStSmart

Edwards Lifesciences Corp (EW)vsSeagate Technology PLC (STX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Seagate Technology PLC generates 75% more annual revenue ($11.01B vs $6.30B). STX leads profitability with a 21.6% profit margin vs 17.4%. STX appears more attractively valued with a PEG of 0.50. STX earns a higher WallStSmart Score of 76/100 (B+).

EW

Buy

61

out of 100

Grade: C+

Growth: 6.0Profit: 7.5Value: 6.0Quality: 4.8
Piotroski: 2/9

STX

Strong Buy

76

out of 100

Grade: B+

Growth: 7.3Profit: 9.0Value: 5.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EWUndervalued (+69.9%)

Margin of Safety

+69.9%

Fair Value

$263.84

Current Price

$82.93

$180.91 discount

UndervaluedFair: $263.84Overvalued

Intrinsic value data unavailable for STX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EW2 strengths · Avg: 9.0/10
Operating MarginProfitability
31.2%10/10

Strong operational efficiency at 31.2%

Revenue GrowthGrowth
16.7%8/10

16.7% revenue growth

STX6 strengths · Avg: 9.7/10
PEG RatioValuation
0.5010/10

Growing faster than its price suggests

Operating MarginProfitability
35.7%10/10

Strong operational efficiency at 35.7%

Revenue GrowthGrowth
44.1%10/10

Revenue surging 44.1% year-over-year

EPS GrowthGrowth
108.3%10/10

Earnings expanding 108.3% YoY

Market CapQuality
$163.00B9/10

Large-cap with strong market position

Profit MarginProfitability
21.6%9/10

Keeps 22 of every $100 in revenue as profit

Areas to Watch

EW3 concerns · Avg: 3.0/10
PEG RatioValuation
2.074/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

P/E RatioValuation
45.4x2/10

Premium valuation, high expectations priced in

STX2 concerns · Avg: 2.0/10
P/E RatioValuation
69.0x2/10

Premium valuation, high expectations priced in

Price/BookValuation
351.7x2/10

Trading at 351.7x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : EW

The strongest argument for EW centers on Operating Margin, Revenue Growth. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.

Bull Case : STX

The strongest argument for STX centers on PEG Ratio, Operating Margin, Revenue Growth. Profitability is solid with margins at 21.6% and operating margin at 35.7%. Revenue growth of 44.1% demonstrates continued momentum.

Bear Case : EW

The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.4x leaves little room for execution misses.

Bear Case : STX

The primary concerns for STX are P/E Ratio, Price/Book. A P/E of 69.0x leaves little room for execution misses.

Key Dynamics to Monitor

STX carries more volatility with a beta of 1.63 — expect wider price swings.

STX is growing revenue faster at 44.1% — sustainability is the question.

STX generates stronger free cash flow (953M), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

STX scores higher overall (76/100 vs 61/100), backed by strong 21.6% margins and 44.1% revenue growth. EW offers better value entry with a 69.9% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Edwards Lifesciences Corp

HEALTHCARE · MEDICAL DEVICES · USA

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.

Visit Website →

Seagate Technology PLC

TECHNOLOGY · COMPUTER HARDWARE · USA

Seagate Technology Holdings plc, an Irish public limited company (commonly referred to as Seagate) is an American data storage company.

Want to dig deeper into these stocks?